Summary & Overview
HCPCS G0452: Molecular Pathology Physician Interpretation and Report
HCPCS Level II code G0452 denotes physician interpretation and reporting of molecular pathology procedures. This code captures the professional component of molecular diagnostic testing—an increasingly important area as precision medicine and genomic testing expand across clinical specialties. Accurate use of G0452 matters nationally because it identifies physician cognitive work in complex test interpretation, supports appropriate payment for specialist expertise, and helps track utilization of high-complexity diagnostics.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical role, common payer considerations, and what to expect in payer coverage patterns. The publication outlines standard documentation elements tied to interpretation and reporting, typical sites of service (clinical laboratories and outpatient pathology services), and the professional focus of the service.
The analysis highlights benchmarks and policy-relevant items: how G0452 fits into molecular pathology billing, areas where payers commonly require specific documentation, and how this code interacts with laboratory testing workflows. Data not provided in the input are noted as unavailable.
Billing Code Overview
HCPCS Level II code G0452 represents a molecular pathology procedure specifically covering physician interpretation and report of molecular diagnostic testing. The service type is interpretation and reporting of molecular pathology results, which typically follows laboratory-based analytic testing.
Typical site of service: clinical laboratory or outpatient pathology service, with the interpretation performed by a qualified physician (pathologist or molecular diagnostician) and the report delivered to the ordering clinician. If additional clinical context is required for billing or documentation, consult payer-specific guidelines.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with a previously diagnosed non–small cell lung carcinoma undergoes molecular testing on a tumor specimen to identify actionable genomic alterations. The specimen (formalin-fixed paraffin-embedded tissue) is submitted to a molecular pathology laboratory. A board-certified molecular pathologist performs interpretation of laboratory-generated molecular assay results (next-generation sequencing panel and single-gene assays), integrates clinical and pathology information, correlates variant pathogenicity with available literature and therapeutic guidelines, and produces a written interpretation and report for the treating oncologist. The workflow includes accessioning, review of clinical history and prior pathology, review of raw and processed molecular data, variant classification, determination of analytical and clinical validity, comment on limitations, and generation of the finalized interpretive report. The physician interpretation and report are billed when the pathologist provides the professional interpretive service distinct from the technical testing component.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the interpretation/report (professional component) separated from the technical laboratory testing. |
TC |